Cocrystal Pharma, Inc.
CDI-988
norovirus infection
Resolved
96days ago
Catalyst readout · Apr 2, 2026
What's at stake
A key catalyst for CDI-988 (norovirus infection) is expected Apr 2, 2026.
Primary source
· SEC 8-K
verified 13h ago
“Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive”